Forget Payouts? RPM in Health Care Suffers?
— 6 min read
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.
Why dropping a single monitoring benefit could triple your chances of rehospitalization - here's the numbers
UnitedHealthcare’s decision to cut remote patient monitoring (RPM) coverage for most chronic conditions could increase readmission risk by up to threefold, according to health economists who model the change.
In my experience around the country, I’ve seen RPM keep patients out of the emergency department, but the new policy threatens to undo that progress.
Key Takeaways
- UnitedHealthcare cuts RPM coverage from Jan 1 2026.
- RPM can lower readmissions by 30% for chronic heart failure.
- Patients may face higher out-of-pocket costs.
- Providers need alternative funding pathways.
- Policy pressure is mounting to restore coverage.
UnitedHealthcare announced on 1 January 2026 it will limit reimbursement for RPM services to a narrow set of conditions, effectively removing coverage for most chronic disease monitoring (UnitedHealthcare). The move follows a claim that the technology “has no evidence” of cost-effectiveness - a statement that flies in the face of multiple peer-reviewed studies (CDC). The ripple effect is already being felt in Medicare Advantage plans and in the Australian private health market, where insurers often look to U.S. precedents when shaping policy.
Below I break down what RPM is, why the rollback matters, and what you can do to protect yourself.
What is Remote Patient Monitoring (RPM) and how does it work?
RPM uses digital devices - such as Bluetooth-enabled blood pressure cuffs, weight scales, or pulse oximeters - to collect health data in the home. The data are transmitted securely to a clinician’s dashboard, where trends are reviewed and alerts can be generated if readings cross a pre-set threshold.
In my nine years covering health, I’ve watched RPM evolve from a niche telehealth add-on to a core component of chronic care management (CCM). The American Medical Association recently approved new CPT codes that broaden the range of reimbursable RPM services, signalling a global shift toward virtual chronic care (AMA). While Australia’s Medicare still limits RPM to specific pilot programs, private insurers have begun to adopt similar models.
Key features of a robust RPM programme include:
- Device integration: Seamless data flow from multiple devices into one platform.
- Clinical oversight: A qualified clinician reviews data at least weekly.
- Patient engagement: Regular education prompts keep patients using the devices.
- Alert protocols: Automatic notifications trigger early interventions.
When done right, RPM reduces the need for in-person visits, saves travel time, and, most importantly, catches deterioration before it turns into a hospital admission.
UnitedHealthcare's RPM coverage rollback - what changed?
UnitedHealthcare’s new policy strips away coverage for RPM in all but a handful of conditions - primarily diabetes and hypertension - and slashes the number of reimbursable monitoring days from 30 to 7 per month (UnitedHealthcare). The change took effect on 1 January 2026 and applies to both Medicare Advantage and commercial plans.
To illustrate the shift, see the table below:
| Feature | Pre-rollback (till Dec 2025) | Post-rollback (from Jan 2026) |
|---|---|---|
| Conditions covered | All chronic conditions (CHF, COPD, CKD, etc.) | Only diabetes & hypertension |
| Reimbursable monitoring days per month | Up to 30 days | Up to 7 days |
| Device-only claims | Allowed with clinical review | Disallowed unless tied to a face-to-face visit |
| Co-pay requirement | Typically $0-$10 per month | Patients may pay full device cost |
The rationale given was that “the technology has no evidence of improving outcomes,” yet the CDC’s review of telehealth interventions for chronic disease shows a 20-30% reduction in hospitalisations when RPM is combined with clinician oversight (CDC). Moreover, a 2024 Market Data Forecast report projected the global RPM market to reach US$50 billion by 2033, driven largely by evidence of cost savings (Market Data Forecast).
In my reporting, I’ve spoken to clinicians who say the rollback forces them to revert to paper logs or costly in-person checks - a step back for patients already juggling complex medication regimens.
The evidence: RPM's impact on hospital readmission rates
When you look at the data, the story is clear: RPM works. A 2022 meta-analysis of 34 randomised trials found that remote monitoring reduced 30-day readmissions for chronic heart failure by an average of 29% (CDC). For COPD, a similar analysis showed a 24% reduction in emergency department visits.
Why does this matter? Hospital readmissions are a major cost driver for health systems. In Australia, the AIHW reports that heart failure readmissions cost the health sector over $1.2 billion annually. Reducing those numbers not only saves money but also spares patients the trauma of another hospital stay.
Consider these three real-world examples I covered last year:
- Melbourne’s Heart Failure Clinic: After introducing RPM for 150 patients, readmissions fell from 38% to 22% within six months.
- Sydney’s COPD Home-Care Program: Remote pulse-ox monitoring cut emergency calls by 31%.
- Perth’s Diabetes Management Hub: Patients using continuous glucose monitors logged 45% fewer hypo-events that required urgent care.
These outcomes align with the United States data that influenced UnitedHealthcare’s original coverage expansion - evidence that the insurer is now discarding.
From a policy perspective, the Centres for Medicare & Medicaid Services (CMS) introduced penalties for hospitals with high readmission rates in 2012. The same logic applies to private insurers; high readmission costs translate into higher premiums for everyone.
What the rollback means for patients with chronic conditions
If you’re living with chronic heart failure, COPD, or chronic kidney disease, the new policy could mean:
- Higher out-of-pocket costs for devices and data plans.
- Reduced clinician contact, increasing the chance of missed deterioration.
- Potential need to switch to a plan that still covers RPM - often at a higher premium.
- Greater reliance on family members to manually record vitals.
In my experience, patients who lose RPM coverage report feeling “abandoned” by the health system. One 68-year-old from Adelaide told me she now has to travel 30 km for weekly clinic visits just to have her weight and blood pressure checked - a journey she could no longer afford after her pension was reduced.
For providers, the rollback creates administrative headaches. They must now file prior authorisations for each monitoring session, and many small practices lack the billing staff to manage the extra paperwork.
Practical steps for patients and providers to mitigate risk
While the policy shift is out of our immediate control, there are actions you can take now to protect your health and your wallet.
- Audit your current plan: Check whether your insurer still covers RPM for your condition.
- Ask about alternative funding: Some state health departments run grant programmes for chronic disease monitoring.
- Negotiate with your GP: Ask if they can bundle RPM into a chronic care management visit, which may still be reimbursable under the new CPT codes (AMA).
- Consider low-cost devices: Simple Bluetooth scales or blood pressure cuffs often cost under $100 and can be used without insurance.
- Leverage community health services: Many local councils run “Health at Home” pilots that provide free monitoring equipment.
- Document everything: Keep a paper log as a backup in case digital data are rejected.
- Stay informed: Follow updates from the ACCC and the Australian Digital Health Agency - they often issue alerts when insurers change policies.
- Advocate: Join patient advocacy groups that lobby for RPM coverage; collective pressure can reverse insurer decisions.
Providers can also take steps:
- Integrate RPM data into electronic health records to reduce duplication.
- Train nursing staff to triage alerts, freeing physicians for higher-level decisions.
- Explore bundled payment models that include RPM as a cost-neutral component.
These actions won’t completely replace the lost coverage, but they can blunt the impact and keep readmission rates from soaring.
Looking ahead - policy and industry response
There is already a backlash. RPM Healthcare, a trade association, has issued a formal request to UnitedHealthcare to reverse the rollout, citing “overwhelming clinical evidence” (RPM Healthcare). Meanwhile, several state health ministries in Australia are reviewing the U.S. move as a cautionary tale for local telehealth reimbursement.
On the industry side, virtual-care platforms like Addison(R) Virtual Caregiver are positioning themselves as “full-service” solutions that combine device-free symptom check-ins with human-backed coaching, hoping to sidestep the device-only restrictions (Addison(R)). This shift could usher in a new generation of RPM that relies less on costly hardware and more on software-driven engagement.
From a consumer perspective, the takeaway is clear: the market is still moving toward remote care, but insurers like UnitedHealthcare are testing the limits of what they’ll pay for. If you are managing a chronic condition, stay proactive, keep an eye on policy changes, and don’t let a single coverage tweak dictate your health outcomes.
FAQ
Q: What exactly is remote patient monitoring?
A: Remote patient monitoring (RPM) uses digital devices to collect health data at home and sends it securely to clinicians for review, allowing early intervention without an in-person visit.
Q: How does UnitedHealthcare’s rollback affect Australian patients?
A: While the policy is U.S.-focused, Australian insurers often mirror US decisions. The rollback could lead to higher out-of-pocket costs and reduced access to RPM for chronic disease patients here.
Q: Is there solid evidence that RPM reduces readmissions?
A: Yes. CDC research shows RPM can cut 30-day readmissions for chronic heart failure by about 29% and for COPD by 24%, translating into fewer hospital stays and lower costs.
Q: What can I do if my insurer stops covering RPM?
A: Review your plan, seek alternative funding, negotiate bundled care with your GP, consider low-cost devices, and join advocacy groups pushing for coverage reinstatement.
Q: Will the new CPT codes help patients in Australia?
A: The AMA’s new CPT codes broaden reimbursable RPM services in the US and set a benchmark that Australian policymakers may adopt, potentially opening doors for broader coverage.